Hypothyroidism — Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine
Citation(s)
Ain KB, Pucino F, Shiver TM, Banks SM Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients. Thyroid. 1993 Summer;3(2):81-5. doi: 10.1089/thy.1993.3.81.
Al-Majdoub M, Lantz M, Spegel P Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels. Thyroid. 2017 Sep;27(9):1109-1117. doi: 10.1089/thy.2017.0218. Epub 2017 Aug 18.
Browning MC, Bennet WM, Kirkaldy AJ, Jung RT Intra-individual variation of thyroxin, triiodothyronine, and thyrotropin in treated hypothyroid patients: implications for monitoring replacement therapy. Clin Chem. 1988 Apr;34(4):696-9.
Czernichow P, Wolf B, Fermanian J, Pomarede R, Rappaport R Twenty-four hour variations of thyroid hormones and thyrotrophin concentrations in hypothyroid infants treated with L-thyroxine. Clin Endocrinol (Oxf). 1984 Oct;21(4):393-7. doi: 10.1111/j.1365-2265.1984.tb03226.x.
Deam DR, Campbell DG, Ratnaike S Effect of oral intake of thyroxine on results of thyroid function tests in patients receiving thyroid replacement therapy. Med J Aust. 1983 Oct 15;2(8):374-6. doi: 10.5694/j.1326-5377.1983.tb122530.x.
Docter R, Krenning EP, de Jong M, Hennemann G The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf). 1993 Nov;39(5):499-518. doi: 10.1111/j.1365-2265.1993.tb02401.x. No abstract available.
Hoermann R, Midgley JE, Larisch R, Dietrich JW Is pituitary TSH an adequate measure of thyroid hormone-controlled homoeostasis during thyroxine treatment? Eur J Endocrinol. 2013 Jan 17;168(2):271-80. doi: 10.1530/EJE-12-0819. Print 2013 Feb.
Hoermann R, Midgley JEM, Dietrich JW, Larisch R Dual control of pituitary thyroid stimulating hormone secretion by thyroxine and triiodothyronine in athyreotic patients. Ther Adv Endocrinol Metab. 2017 Jun;8(6):83-95. doi: 10.1177/2042018817716401. Epub 2017 Jul 13.
Iwayama H, Sugahara K, Nakano M, Fukayama M, Okumura A Measurement of reverse triiodothyronine levels using liquid chromatography-tandem mass spectrometry in the serum of 89 outpatients. Medical Mass Spectrometry. 2017;1(1):10-3.
Peterson SJ, McAninch EA, Bianco AC Is a Normal TSH Synonymous With "Euthyroidism" in Levothyroxine Monotherapy? J Clin Endocrinol Metab. 2016 Dec;101(12):4964-4973. doi: 10.1210/jc.2016-2660. Epub 2016 Oct 4. Erratum In: J Clin Endocrinol Metab. 2017 Apr 1;102(4):1406.
Saravanan P, Siddique H, Simmons DJ, Greenwood R, Dayan CM Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy. Exp Clin Endocrinol Diabetes. 2007 Apr;115(4):261-7. doi: 10.1055/s-2007-973071.
Soppi E, Irjala K, Kaihola HL, Viikari J Acute effect of exogenous thyroxine dose on serum thyroxine and thyrotrophin levels in treated hypothyroid patients. Scand J Clin Lab Invest. 1984 Jun;44(4):353-6. doi: 10.3109/00365518409083819.
Strich D, Chay C, Karavani G, Edri S, Gillis D Levothyroxine Therapy Achieves Physiological FT3/FT4 Ratios at Higher than Normal TSH Levels: A Novel Justification for T3 Supplementation? Horm Metab Res. 2018 Nov;50(11):827-831. doi: 10.1055/a-0751-0498. Epub 2018 Nov 5.
Symons RG, Murphy LJ Acute changes in thyroid function tests following ingestion of thyroxine. Clin Endocrinol (Oxf). 1983 Oct;19(4):539-46. doi: 10.1111/j.1365-2265.1983.tb00029.x.
Wennlund A Variation in serum levels of T3, T4, FT4 and TSH during thyroxine replacement therapy. Acta Endocrinol (Copenh). 1986 Sep;113(1):47-9. doi: 10.1530/acta.0.1130047.
Woeber KA Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest. 2002 Feb;25(2):106-9. doi: 10.1007/BF03343972.
Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
